Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nano Regulatory News (ONT)

Share Price Information for Oxford Nano (ONT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.05
Bid: 96.95
Ask: 97.20
Change: -0.30 (-0.31%)
Spread: 0.25 (0.258%)
Open: 97.40
High: 97.75
Low: 94.80
Prev. Close: 97.05
ONT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Annual Report and Notice of AGM

12 Apr 2022 07:00

RNS Number : 0372I
Oxford Nanopore Technologies plc
12 April 2022
 

12 April 2022

Oxford Nanopore Technologies plc

(the "Company")

Publication of 2021 Annual Report and Notice of Annual General Meeting

 

Oxford Nanopore Technologies plc, the company behind a new generation of nanopore-based sequencing technology, today announces that it has published its Annual Report and Accounts for the year ended 31 December 2021 and its Notice of Annual General Meeting 2022.

In compliance with Listing Rule 9.6.3, the following documents have today been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

· Annual Report and Accounts for the year ended 31 December 2021 ("2021 ARA"); and

· Notice of 2022 Annual General Meeting ("2022 AGM Notice").

Printed copies of these documents together with the Form of Proxy for use in connection with the 2022 Annual General Meeting have been posted to shareholders who have requested hard copies. Electronic copies of the 2021 ARA and 2022 AGM Notice are available on the Investor Relations section of the Company's website at https://nanoporetech.com/about-us/investors.

The 2022 Annual General Meeting will be held at the Company's offices at Gosling Building, Edmund Halley Road, Oxford Science Park, Oxford, OX4 4DQ at 11.00am on Thursday 23 June 2022.

At the time of publication of this Notice, there are no UK government restrictions that prevent the Company from holding its AGM in person. If the Covid-19 guidance changes at any point prior to the AGM, such that shareholders are unable to attend in person, the Company will update shareholders through an announcement to the London Stock Exchange and on the Company's website at https://nanoporetech.com/about-us/investors. Shareholders who plan to attend the AGM in person should take a lateral flow test and ensure a negative result before entering the Company's offices. Shareholders should not attend if they are displaying any symptoms of Covid-19.

Shareholders are strongly encouraged to ensure that their votes are counted at the 2022 Annual General Meeting by appointing the chair of the 2022 Annual General Meeting as their proxy in line with the procedures set out in the 2022 AGM Notice.

[ENDS]

For further information please contact:

Oxford Nanopore Technologies plc

Hannah Coote, Company Secretary

cosec@nanoporetech.com 

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 120 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer. Oxford Nanopore's technology also has the potential to provide broad, high impact, rapid insights in a number of areas including healthcare, food and agriculture. 

 

Oxford Nanopore devices sequence DNA and RNA directly and sequence short to ultra-long fragments of DNA, for a truly comprehensive picture of the genome. Data is streamed in real-time and can enable rapid insights. The technology is fully scalable - from pocket-sized to ultra-high throughput devices. 

 

For more information please visit: www.nanoporetech.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOADBGDSLGBDGDB
Date   Source Headline
2nd Oct 20234:00 pmRNSIssue of Equity and Total Voting Rights
27th Sep 20235:00 pmRNSDirector Declaration
12th Sep 20233:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Sep 20237:00 amRNSPresentation at the Morgan Stanley Conference
6th Sep 20237:00 amRNSInterim results for the 6 months ended 30 June 23
1st Sep 20233:00 pmRNSIssue of Equity and Total Voting Rights
25th Aug 202312:00 pmRNSNotice of Results and Capital Markets Day
11th Aug 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20235:30 pmRNSIssue of Equity and Total Voting Rights
17th Jul 20237:00 amRNSHalf Year Trading Update
13th Jul 20233:30 pmRNSKate Priestman appointed as Non-Executive Director
11th Jul 20235:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
13th Jun 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Jun 20233:30 pmRNSResult of AGM
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.